Related Experiment Video
Updated: Jun 26, 2026

Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres
Published on: November 21, 2025
Frequency of microemboli signal in stroke patients treated with low molecular weight heparin or aspirin
Qing Hao1, Hui Meng Chang, Meng Cheong Wong
1Department of Medicine &Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Background And Purpose:
Microemboli signal (MES) detected by transcranial Doppler (TCD) may represent ongoing embolic phenomenon and is a predictor of recurrent stroke or transient ischemic attack. We sought to study the frequency of MES in stroke patients with large artery occlusive diseases treated with low molecular weight heparin (LMWH) or aspirin.
Methods:
Patients participating in the Fraxiparine in Ischemic Stroke (FISS)-tris study were recruited. MES detection was performed from middle cerebral artery on the 1st, 3rd, and 7th days after randomization. The correlation between the presence of MES and the treatment was determined by the chi(2) test.
Results:
Among 47 patients, 26 were randomized to LMWH and 21 to aspirin. On day 1, MES were detected in 10 patients (7/26 on LMWH, 3/21 on aspirin; P= .475). On day 3, 12 patients had MES (7/25 on LMWH, 5/20 on aspirin; P= .821). On day 7, 11 patients had MES (6/25 on LMWH, 5/20 on aspirin; P= .938). The median of the number of MES on days 1, 3, and 7 was 4 (range 1-10), 5 (range 1-42), and 3 (range 1-33) for the LMWH group and 1 (range 1-15), 4 (range 1-10), and 2 (range 1-4) for the aspirin group.
Conclusions:
There were no significant differences in the frequency of MES between patients with large artery occlusive disease treated with LMWH and aspirin.
Insights
Microemboli signals (MES) in stroke patients did not differ significantly between those treated with low molecular weight heparin (LMWH) and aspirin. Transcranial Doppler (TCD) monitoring showed similar MES frequencies, indicating comparable embolic phenomena in both treatment groups.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Medical Imaging
Background:
- Microemboli signals (MES) detected via transcranial Doppler (TCD) indicate ongoing embolic phenomena.
- MES presence predicts recurrent stroke or transient ischemic attack.
- Large artery occlusive diseases are a significant cause of stroke.
Purpose of the Study:
- To investigate the frequency of MES in stroke patients with large artery occlusive diseases.
- To compare MES frequency between patients treated with low molecular weight heparin (LMWH) and aspirin.
Main Methods:
- Patients from the Fraxiparine in Ischemic Stroke (FISS)-tris study were analyzed.
- MES detection was performed using transcranial Doppler (TCD) on days 1, 3, and 7 post-randomization.
- The chi-squared test was used to determine the correlation between MES presence and treatment allocation.
Main Results:
- No significant difference in MES detection rates between LMWH and aspirin groups on days 1 (P=.475), 3 (P=.821), and 7 (P=.938).
- Median MES counts showed no significant variations between the LMWH and aspirin groups across the study days.
- The study included 47 patients, with 26 randomized to LMWH and 21 to aspirin.
Conclusions:
- Treatment with LMWH or aspirin did not result in a significant difference in MES frequency.
- This suggests comparable management of embolic phenomena in large artery occlusive disease stroke patients treated with LMWH versus aspirin.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Ischemic Stroke l: Introduction
Venous Thrombosis IV: Nursing Management
Hemorrhagic Stroke ll: Pathophysiology
